A First-In-Human Study of ARO-033 in Adult Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), andpharmacodynamics (PD) of single and multiple doses of ARO‐033 compared to placebo inadult normal healthy volunteers (NHVs).
Epistemonikos ID: a4a58ee38c5fe2c36b406b47bdbba2ada86381e8
First added on: Jun 23, 2026